Du är här


Episurf Medical launches German website and increases marketing efforts in the region

Episurf Medical AB
Company Announcement

Episurf Medical launches German website and increases marketing efforts in the

In line with planned expansion in the German market, Episurf Medical has
launched its German website. The new website is aimed to support the company's
accelerated penetration plans in the region and further enable Episurf Medical
to reach out with information specifically targeted to German-speaking
physicians and prospective patients.

This information was published, 2016-01-18 13:05 CET (GLOBE NEWSWIRE) --

“Germany is one of our key markets and the European country where most knee
related surgical interventions are performed. We have received excellent
feedback from German surgeons about our intelligent, patient specific implant
technology and are excited to provide German customers and new users with even
better service through specific German language information,” says Rosemary
Cunningham Thomas, CEO, Episurf Medical.

In 2015, Episurf Medical made key recruitments to establish the core German
sales organisation, which is expected to grow with four additional sales
representatives in 2016.

The website can be reached directly from www.episurf.de as well as a direct
link on the www.episurf.com website.

About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a
more active, healthier life through the availability of minimally invasive and
personalized treatment alternatives. Episurf Medical’s Episealer® personalized
implants and Epiguide® surgical drill guides are in development for treating
localized cartilage injury in joints. Episurf Medical’s ?iFidelity® system will
enable implants to be cost-efficiently tailored to each individual’s unique
injury for the optimal fit and minimal intervention.

Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is
listed on Nasdaq Stockholm. For more information, go to the company’s website:
www.episurf.com. The information in this press release is such that Episurf
Medical AB is required to disclose in accordance with the Securities Markets
Act and/or the Financial Instruments Trading Act.

For more information, please contact:
Rosemary Cunningham Thomas, CEO, Episurf Medical
Tel: +46 (0) 70-7655892
Tel: +44 (0) 7803-753603
E-mail: rosemary@episurf.com

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.